Author | Yuman Fong, MD


The Evolution of Liver-Directed Treatments for Hepatic Colorectal Metastases

November 15, 2014

This article will review the current practice of hepatic resection for colorectal liver metastases, including the possibility of combined resection of hepatic metastases at the time of resection of the primary cancer.

Commentary (Fong): Management of Hepatocellular Carcinoma

July 01, 2000

Hepatocellular carcinoma (HCC) is the most common solid organ tumor worldwide. In recent decades, diagnosis and treatment of this cancer has evolved significantly. The article by Drs. Nakakura and Choti summarizes many of the advances in this field, delineates the current evidence-based treatment options, and defines promising areas for future study.

Hepatic Colorectal Metastasis: Current Status of Surgical Therapy

October 01, 1998

Metastatic colorectal cancer to the liver develops in over 50,000 US patients each year and is rapidly fatal if untreated. Even the most active chemotherapeutic agents rarely prolong survival for more than 3 years. Liver